weeks 1316 1.7 mg/week
Lets see what existing studiesalbeit mostly in animalstell us
The genes affected by semaglutide included markers of inflammation and plaque stability that are associated with leukocyte recruitment [e.g., interleukin-1 (IL-1) receptor antagonist, IL-6, monocyte chemoattractant protein (CCL2), OPN], leukocyte adhesion [selectin E, vascular cell adhesion molecule-1 (VCAM1)], leukocyte extravasation and plaque stability (e.g., MMP3, MMP13, CCL2), and plaque rupture and hemorrhage (CD163)
GBS is a well-validated score which consists of 4 components: medical history (hepatic disease, heart failure), symptoms (melaena, syncope), signs (tachycardia, blood pressure), and blood tests (haemoglobin, blood urea nitrogen)
Fuente: Diario Mdico Referencia: Vilsbll T, Christensen M, Junker AE et al
How Much Weight Loss to Expect Semaglutide trials typically show average weight loss of around 15 percent at higher doses